NASDAQ$OMDA
Omada Health Inc · Q2 2025 earnings
Q2 2025 earnings ·
Briefing
Omada Health reported Q2 2025 revenue of $61.4M, a net loss of $5.3M, diluted EPS of $-0.24.
For Q2 2025, Omada Health reported Revenue was $61.4M, net loss was $5.3M, diluted EPS was $-0.24. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $61.4M for Q2 2025.
- Net loss $5.3M.
- Diluted EPS $-0.24.
Headline financials
Revenue & EPS history
Omada Health Inc · Revenue · Quarterly
$61.4M
Forward guidance
Outlook emphasizes path to profitability, liquidity runway, and cost discipline.
Tailwinds
- Operating initiatives and partnership milestones.
- Cash and revolver capacity extend runway.
Headwinds
- Operating losses and dilution risk.
- Competitive and regulatory uncertainty.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 4 quarterly earnings reports · overlaid with Q2 2025
-3.9%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+1.7%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+3.3%
Q4 2025
Best reaction
-9.5%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.5% | -2.1% | +9.4% | |
| Q4 2025 | +3.3% | +1.0% | -7.5% | |
| Q3 2025 | -7.1% | -1.9% | -20.0% | |
| Q2 2025 | -2.3% | +3.2% | +24.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro